News

Pfizer’s Launched and Acquired Drugs Grew 32% in Q3 — and 3 Other Reasons to Buy the Stock Before 2027

Pfizer’s Launched and Acquired Drugs Grew 32% in Q3 — and 3 Other Reasons to Buy the Stock Before 2027

Pfizer remains deeply unloved on Wall Street, but it is slowly turning a corner.

The Motley Fool
Weekend Reading For Financial Planners (November 21–22)

Weekend Reading For Financial Planners (November 21–22)

Enjoy the current installment of “Weekend Reading For Financial Planners” – this week’s edition kicks off with the news that the Department of Labor this week issued a final rule reversing Biden-era regulations originally intended to broaden the types of workers who would be shifting from independent contractors to instead be categorized as employees. The […]

Michael Kitces